Subcutaneous Drug Delivery Devices

Subcutaneous Drug Delivery Devices Market Size to Hit US$ 56.9 Billion By 2030

The global subcutaneous drug delivery devices market size is forecasted to hit from US$ 25.53 billion in 2021 to US$ 56.9 billion by 2030, growing at a CAGR of 9.3% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research. The rising adoption of the various subcutaneous drug delivery devices by consumers to control and manage their chronic health conditions is fueling market growth.

The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030.

This growth, according to the report, is due to the increased number of chronic disease prevalence around the globe, the significant number of vaccination and immunization programs that incorporate the use of subcutaneous drug delivery devices for therapeutic administration, and a rise in the R&D of new products leading to the subsequent introduction of novel solutions and devices in the market.

However, the risk of infections and other diseases associated with the use of injections and syringes is likely to hamper the market growth.

The study further states that the increased investment that companies are making into R&D is also aiding in the increase of the global subcutaneous drug delivery devices market.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1490

Scope of the Subcutaneous Drug Delivery Devices Market

Report Coverage Details
Market Size USD 56.9 Billion by 2030
Growth Rate from 2021 to 2030 9.3%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Product, Distribution Channel, Region

COVID-19 has led to increasing in-home care treatments

COVID-19 cases have been increasing day by day almost all over the globe. The fatality of this virus especially for people already suffering from high blood pressure, diabetes, or other chronic diseases is tremendously high. People with these kinds of health issues prefer to stay at home and avoid going to any public places. Visiting hospitals, care centers or solo clinics for regular medication can be fatal or harmful for these patients. This pandemic situation thus has surged the demand for home medication drug delivery devices. Drug delivery devices providing self-medication abilities will help people to medicate themselves without stepping out of the house, thus saving them from dangerous impacts that the COVID-19 virus could cause.

Market Trends

The escalating awareness about the benefits of subcutaneous drug delivery devices is bringing tremendous growth opportunities. With a large number of individuals preferring eCommerce platforms for ordering these devices, the players are making efforts to increase their online presence. Novel devices are also creating a substantial buzz in the subcutaneous drug delivery devices market. Researchers at MIT recently developed a double-barreled syringe for subcutaneous biologics injections.

Wearable injectors may also bring a good growth share for the subcutaneous drug delivery devices market during the forecast period of 2021-2030.

Competitive Intelligence

The report provides an understanding of the market composition and explains the role of established players and regional contributors. It is essential for the market players to make calculative moves and focus on client acquisition and retention. The detailed company profiles will provide the necessary intelligence to the reader. In order to maintain their share, the market players are focusing on strategies such as cross-border expansion, product differentiation and so on.

Some of the prominent players in the global subcutaneous drug delivery devices market are listed as below:

  • Insulet Corporation
  • Enable Injections
  • Amgen
  • BD
  • Consort Medical Plc
  • Ypsomed AG
  • Eli Lilly
  • Novo Nordisk
  • Sanofi
  • Merck
  • AstraZeneca

Segments Covered in the Report

By Product Type

  • Auto-Injectors
  • Pen Injectors
  • Prefilled Syringes
  • Wearable Injectors
  • Needle-Free Injectors

By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Regional Segmentation

– North America (U.S. and Canada)

– Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

– Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

– Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Subcutaneous Drug Delivery Devices Market

5.1. COVID-19 Landscape: Subcutaneous Drug Delivery Devices Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Subcutaneous Drug Delivery Devices Market, By Product

8.1. Subcutaneous Drug Delivery Devices Market, by Product Type, 2021-2030

8.1.1. Auto-Injectors

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Pen Injectors

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Prefilled Syringes

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Wearable Injectors

8.1.4.1. Market Revenue and Forecast (2019-2030)

8.1.5. Needle-Free Injectors

8.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Subcutaneous Drug Delivery Devices Market, By Distribution Channel

9.1. Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2021-2030

9.1.1. Retail Pharmacies

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Hospital Pharmacies

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Online Pharmacies

9.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Subcutaneous Drug Delivery Devices Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Product (2019-2030)

10.1.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.1.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.1.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.5.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.6.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.5.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.6.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.5.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.6.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.5.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.5.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.5.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

Chapter 11. Company Profiles

11.1. Insulet Corporation

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Enable Injections

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Amgen

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. BD

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Consort Medical Plc

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Ypsomed AG

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Eli Lilly

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Novo Nordisk

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Sanofi

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Merck

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

11.11. AstraZeneca

11.11.1. Company Overview

11.11.2. Product Offerings

11.11.3. Financial Performance

11.11.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global subcutaneous drug delivery devices market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for subcutaneous drug delivery devices are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1490

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com


691bc270febec6aa2d88d2cf3341df96?s=96&d=mm&r=g

US Web Wire

US Web Wire is a leading independent Online News and Print Magazine source, which has evolved from the growing need to have a more balanced view, for informative and independent news within the healthcare it community, global automotive, and financial community. Email: info@uswebwire.com

US Web Wire

US Web Wire is a leading independent Online News and Print Magazine source, which has evolved from the growing need to have a more balanced view, for informative and independent news within the healthcare it community, global automotive, and financial community. Email: info@uswebwire.com

View all posts by US Web Wire →

Leave a Reply

Your email address will not be published. Required fields are marked *